Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 5
2003 5
2004 11
2005 9
2006 10
2007 14
2008 11
2009 15
2010 17
2011 14
2012 24
2013 27
2014 35
2015 35
2016 46
2017 38
2018 36
2019 52
2020 59
2021 83
2022 59
2023 60
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

623 results

Results by year

Filters applied: . Clear all
Page 1
Should children be vaccinated against COVID-19?
Zimmermann P, Pittet LF, Finn A, Pollard AJ, Curtis N. Zimmermann P, et al. Among authors: pollard aj. Arch Dis Child. 2022 Mar;107(3):e1. doi: 10.1136/archdischild-2021-323040. Epub 2021 Nov 3. Arch Dis Child. 2022. PMID: 34732388 Review.
Typhoid fever.
Meiring JE, Khanam F, Basnyat B, Charles RC, Crump JA, Debellut F, Holt KE, Kariuki S, Mugisha E, Neuzil KM, Parry CM, Pitzer VE, Pollard AJ, Qadri F, Gordon MA. Meiring JE, et al. Among authors: pollard aj. Nat Rev Dis Primers. 2023 Dec 14;9(1):71. doi: 10.1038/s41572-023-00480-z. Nat Rev Dis Primers. 2023. PMID: 38097589 Review.
Viral vector vaccines.
McCann N, O'Connor D, Lambe T, Pollard AJ. McCann N, et al. Among authors: pollard aj. Curr Opin Immunol. 2022 Aug;77:102210. doi: 10.1016/j.coi.2022.102210. Epub 2022 May 25. Curr Opin Immunol. 2022. PMID: 35643023 Free PMC article. Review.
Epidemiology and Immune Pathogenesis of Viral Sepsis.
Lin GL, McGinley JP, Drysdale SB, Pollard AJ. Lin GL, et al. Among authors: pollard aj. Front Immunol. 2018 Sep 27;9:2147. doi: 10.3389/fimmu.2018.02147. eCollection 2018. Front Immunol. 2018. PMID: 30319615 Free PMC article. Review.
Vaccine safety issues at the turn of the 21st century.
Conklin L, Hviid A, Orenstein WA, Pollard AJ, Wharton M, Zuber P. Conklin L, et al. Among authors: pollard aj. BMJ Glob Health. 2021 May;6(Suppl 2):e004898. doi: 10.1136/bmjgh-2020-004898. BMJ Glob Health. 2021. PMID: 34011504 Free PMC article. Review.
The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study.
Wildenbeest JG, Billard MN, Zuurbier RP, Korsten K, Langedijk AC, van de Ven PM, Snape MD, Drysdale SB, Pollard AJ, Robinson H, Heikkinen T, Cunningham S, O'Neill T, Rizkalla B, Dacosta-Urbieta A, Martinón-Torres F, van Houten MA, Bont LJ; RESCEU Investigators. Wildenbeest JG, et al. Among authors: pollard aj. Lancet Respir Med. 2023 Apr;11(4):341-353. doi: 10.1016/S2213-2600(22)00414-3. Epub 2022 Nov 10. Lancet Respir Med. 2023. PMID: 36372082 Free PMC article.
Preface.
Curtis N, Pollard AJ, Finn A, Ramilo O, Dobson S, Warris A, van Rossum A. Curtis N, et al. Among authors: pollard aj. J Infect. 2017 Jun;74 Suppl 1:S1. doi: 10.1016/S0163-4453(17)30183-4. J Infect. 2017. PMID: 28646946 No abstract available.
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum.
Tuekprakhon A, Nutalai R, Dijokaite-Guraliuc A, Zhou D, Ginn HM, Selvaraj M, Liu C, Mentzer AJ, Supasa P, Duyvesteyn HME, Das R, Skelly D, Ritter TG, Amini A, Bibi S, Adele S, Johnson SA, Constantinides B, Webster H, Temperton N, Klenerman P, Barnes E, Dunachie SJ, Crook D, Pollard AJ, Lambe T, Goulder P, Paterson NG, Williams MA, Hall DR; OPTIC Consortium; ISARIC4C Consortium; Fry EE, Huo J, Mongkolsapaya J, Ren J, Stuart DI, Screaton GR. Tuekprakhon A, et al. Among authors: pollard aj. Cell. 2022 Jul 7;185(14):2422-2433.e13. doi: 10.1016/j.cell.2022.06.005. Epub 2022 Jun 9. Cell. 2022. PMID: 35772405 Free PMC article.
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, Bibi S, Briner C, Cicconi P, Collins AM, Colin-Jones R, Cutland CL, Darton TC, Dheda K, Duncan CJA, Emary KRW, Ewer KJ, Fairlie L, Faust SN, Feng S, Ferreira DM, Finn A, Goodman AL, Green CM, Green CA, Heath PT, Hill C, Hill H, Hirsch I, Hodgson SHC, Izu A, Jackson S, Jenkin D, Joe CCD, Kerridge S, Koen A, Kwatra G, Lazarus R, Lawrie AM, Lelliott A, Libri V, Lillie PJ, Mallory R, Mendes AVA, Milan EP, Minassian AM, McGregor A, Morrison H, Mujadidi YF, Nana A, O'Reilly PJ, Padayachee SD, Pittella A, Plested E, Pollock KM, Ramasamy MN, Rhead S, Schwarzbold AV, Singh N, Smith A, Song R, Snape MD, Sprinz E, Sutherland RK, Tarrant R, Thomson EC, Török ME, Toshner M, Turner DPJ, Vekemans J, Villafana TL, Watson MEE, Williams CJ, Douglas AD, Hill AVS, Lambe T, Gilbert SC, Pollard AJ; Oxford COVID Vaccine Trial Group. Voysey M, et al. Among authors: pollard aj. Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8. Lancet. 2021. PMID: 33306989 Free PMC article. Clinical Trial.
623 results